Acumen Pharmaceuticals (ABOS) Other Working Capital Changes (2020 - 2026)
Acumen Pharmaceuticals recorded quarterly Other Working Capital Changes of -$691000.0 in Q1 2026, down 340.13% quarter-over-quarter from -$157000.0 in Q4 2025, and down 4218.75% year-over-year from $16776.9 in Q1 2025.
Acumen Pharmaceuticals' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$691000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 4218.75% year-over-year to -$691000.0; the TTM figure through Mar 2026 stood at -$2.0 million (down 3603.64% YoY), while the FY2025 annual figure was -$1.4 million, down 1740.54% from the prior year.
- Other Working Capital Changes came in at -$691000.0 for Q1 2026 at Acumen Pharmaceuticals, down from -$157000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.4 million in Q2 2024 to a low of -$4.3 million in Q4 2024.
- A 5-year average of -$203411.8 and a median of -$16000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes jumped 227.37% in 2024 and sank 4218.75% in 2026, its largest moves.
- Acumen Pharmaceuticals' Other Working Capital Changes stood at $358000.0 in 2022, then slipped by 7.54% to $331000.0 in 2023, then tumbled by 1390.03% to -$4.3 million in 2024, then surged by 96.32% to -$157000.0 in 2025, then tumbled by 340.13% to -$691000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$691000.0, -$157000.0, and -$1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -691,000.00 |
| Mar 31, 2026 | -691,000.00 |
| Dec 31, 2025 | -157,000.00 |
| Dec 31, 2025 | -157,000.00 |
| Sep 30, 2025 | -1.19 Mn |
| Sep 30, 2025 | -1.19 Mn |
| Jun 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -16,000.00 |
| Mar 31, 2025 | -16,000.00 |
| Dec 31, 2024 | -4.27 Mn |
| Dec 31, 2024 | -4.27 Mn |
| Sep 30, 2024 | 846,000.00 |
| Sep 30, 2024 | 846,000.00 |
| Jun 30, 2024 | 3.39 Mn |
| Jun 30, 2024 | 3.39 Mn |
| Mar 31, 2024 | -35,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Dec 31, 2023 | 331,000.00 |
| Dec 31, 2023 | 331,000.00 |
| Sep 30, 2023 | -1.90 Mn |
| Sep 30, 2023 | -1.90 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 899,000.00 |
| Mar 31, 2023 | 899,000.00 |
| Dec 31, 2022 | 358,000.00 |
| Dec 31, 2022 | 358,000.00 |
| Sep 30, 2022 | 1.22 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | -1.87 Mn |
| Jun 30, 2022 | -1.87 Mn |
| Mar 31, 2022 | -1.42 Mn |
| Mar 31, 2022 | -1.42 Mn |
| Dec 31, 2021 | -4.30 Mn |
| Dec 31, 2021 | -4.30 Mn |
| Sep 30, 2021 | 3.19 Mn |
| Sep 30, 2021 | 3.19 Mn |
| Jun 30, 2021 | 1.06 Mn |
| Jun 30, 2021 | 1.06 Mn |
| Mar 31, 2021 | 44,000.00 |
| Mar 31, 2021 | 44,000.00 |
| Dec 31, 2020 | 408,000.00 |
| Dec 31, 2020 | 408,000.00 |
| Sep 30, 2020 | -731,000.00 |
| Sep 30, 2020 | -731,000.00 |